Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improve

Laurus Labs’ stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in expanding capacities, particularly for high-value CDMO services, which are projected to double their revenue share by 2030. Analysts are optimistic, raising earnings forecasts and maintaining a ‘BUY’…

Tata Chemicals surges on Tata Sons listing buzz

Tata Chemicals shares surged on Thursday, driven by the RBI’s new guidelines for upper-layer NBFCs, sparking hopes for a Tata Sons listing. Analysts suggest this could unlock significant value for Tata Chemicals, which holds a stake in the unlisted entity. The potential listing of Tata Sons, valued in the unlisted market, could boost Tata Chemicals’…